Table 3 Univariate survival analysis of different prognostic factors in 201 patients with NPC
From: p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
Variable | All cases | Mean survival (months) | Chi-square value | P-value |
|---|---|---|---|---|
Gender | 2.291 | 0.130 | ||
Male | 144 | 125.36 | ||
Female | 57 | 142.17 | ||
Age | 6.644 | 0.010 | ||
≤45.89 | 104 | 141.09 | ||
>45.89 | 97 | 118.95 | ||
Clinical stage | 5.310 | 0.021 | ||
I-II | 39 | 149.60 | ||
III-IV | 162 | 126.65 | ||
T stage | 4.323 | 0.038 | ||
T1 + T2 | 64 | 142.54 | ||
T3 + T4 | 137 | 123.32 | ||
N stage | 3.915 | 0.048 | ||
N0 | 28 | 146.06 | ||
N1 + N2 + N3 | 173 | 129.18 | ||
Therapy | 2.841 | 0.417 | ||
Regimen 1 | 50 | 122.82 | ||
Regimen 2 | 72 | 133.64 | ||
Regimen 3 | 31 | 127.82 | ||
Regimen 4 | 48 | 122.49 | ||
Relapse | 32.95 | 0.000 | ||
No | 171 | 138.15 | ||
Yes | 30 | 91.75 | ||
Expression | ||||
Low | 124 | 121.63 | 6.347 | 0.012 |
High | 77 | 143.32 |